Seroatlas · Human Serome Atlas

CELF2-AS1

Putative uncharacterized protein CELF2-AS1

Also known as: CEAS1_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: Q8N7Q2
Gene: CELF2-AS1
Canonical length: 184 aa

OverviewNCBI Gene

No narrative summary is available for CELF2-AS1 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

184 residues, UniProt reviewed canonical sequence.

>Q8N7Q2|CELF2-AS1
     1  MFCLLHLCFY LANFASSIKR THAVNGCCGL QMIALWAQSS GNADARVEEI LAGEERRLAA
    61  LLGSQGMRFW VCLAACRAMW GLAARRGRAE DSSSSPVDAS KFPWRGGQHR TTMMPCLLRV
   121  GVFRPCHVRP TGDPSCDVQP PRLGFSRVPD TQVAFYGSGH WDPTPFSVHS CFFNFQVRKI
   181  IFLL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CELF2-AS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Secreted
Secreted: Yes
Transmembrane segments: 0
Mean surface accessibility (rSASA): 0.46

OntologyGO

Cellular components

extracellular region

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CELF2-AS1 as an antibody target. Whether an autoantibody or antibody against CELF2-AS1 could matter depends on whether native CELF2-AS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CELF2-AS1 is annotated as secreted, so native CELF2-AS1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CELF2-AS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...